N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide

Catalog No. :
ACSQFV821
CAS No. :
104617-50-7
Molecular Formula :
C9H14BrN3OS
Molecular Weight :
292.20

IUPAC Name:N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide

N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide
IUPAC NameN-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide
Molecular FormulaC9H14BrN3OS
Molecular Weight292.20
SMILESCC(NC(C1)CCC2=C1SC(N)=N2)=O.[H]Br
InChI KeyXDWSUEPXEWCNIX-UHFFFAOYSA-N
SynonymN-(2-AMino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetaMide HydrobroMide;[N-(2-Amino-4,5,6,7- tetra hydro benzo(d) thiazol-6-yl) acetamide hydro bromide;N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide monohydrobromide;N-(2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide hydrobromide;N-[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide hydrobromide;N-(2-Methyl-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acetamide hydrobromide
CAS No.104617-50-7

Synthetic Route by SureRoute

1. ACSQFV821 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSQFV821 route product structure diagram
    ACSQFV821104617-50-7
Inquiry

2. ACSQFV821 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBXVG178 route compound structure diagram
    ACBXVG178104617-49-4
  4. Then
  5. ACSQFV821 route product structure diagram
    ACSQFV821104617-50-7
Inquiry

Comments (0)